ALEC Earnings Date: Nov 5, 2026 (Estimated) — Alector, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is ALEC's next earnings date?
Alector, Inc. (ALEC) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.23 on revenue of $2.2M.
How did ALEC do in its last earnings report?
In its most recent report on Aug 6, 2026 (Q2 2026), Alector, Inc. posted EPS of -$0.21 versus the -$0.23 estimate, a beat of 8.7%. Revenue was $3.3M against a $1.7M estimate. The stock's 1-day post-earnings move was -2.7%.
How much does ALEC stock move after earnings?
ALEC beat EPS estimates in 8 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 10.9% (up or down) in the day after earnings.
About Alector, Inc.
Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | -0.23 | -0.21 | +8.70% | $3.3M | ✅ Beat | -2.73% | +11.48% | +34.43% |
| 2026-05-07 | Q1 2026 | -0.29 | -0.21 | +27.59% | $1.0M | ✅ Beat | -13.93% | -5.74% | -32.79% |
| 2026-02-25 | Q4 2025 | -0.37 | -0.34 | +8.11% | $6.2M | ✅ Beat | +7.11% | -10.04% | -11.30% |
| 2025-11-06 | Q3 2025 | -0.42 | -0.34 | +19.05% | $3.3M | ✅ Beat | -1.54% | -7.69% | -6.15% |
| 2025-08-07 | Q2 2025 | -0.46 | -0.30 | +34.78% | $7.9M | ✅ Beat | +47.26% | +68.49% | +89.04% |
| 2025-02-26 | Q4 2024 | -0.54 | -0.02 | +96.30% | $54.2M | ✅ Beat | -3.49% | -9.88% | -22.67% |
| 2024-11-06 | Q3 2024 | -0.53 | -0.43 | +18.87% | $15.3M | ✅ Beat | +7.63% | -2.19% | -58.78% |
| 2024-08-07 | Q2 2024 | -0.50 | -0.40 | +20.00% | $15.1M | ✅ Beat | +3.87% | -1.02% | -1.22% |
Showing last 8 quarters.